Table 2 Baseline outcomes of interest by group status.

From: Efficacy and feasibility of the BREATHE asthma intervention with American Indian children: a randomized controlled trial

 

BREATHE intervention (N = 53)

Non-intervention (N = 55)

Lab test

N (%)

N (%)

NicAlert positive for cotinine

38 (71.7)

40 (72.7)

Questionnaire (self-report)

N (%)

N (%)

Persistent cough in past 4 weeks

23 (46.0)

28 (50.9)

Wheezing in past 4 weeks

24 (48.0)

32 (59.3)

Difficult time breathing in past 4 weeks

21 (42.0)

31 (56.4)

Prescribed meds not taken

11 (21.6)

13 (23.6)

Smoking allowed in home

17 (32.1)

11 (20.0)

Smoking allowed outside of home

31 (58.5)

43 (78.2)

Smoking allowed in vehicle

17 (32.1)

21 (38.2)

Questionnaire (self-report)

Mean (SD)

Mean (SD)

Asthma Control

18.57 (4.09)

19.69 (4.38)

Asthma life quality—child

9.24 (4.22)

7.88 (4.36)

Asthma life quality—parent

10.27 (4.54)

9.04 (4.74)

Asthma knowledge

8.90 (1.64)

9.02 (1.62)

Chart review (24 months prior to enrollment)

Mean (SD)

Median (interquartile range)

Minimum/maximum

Mean (SD)

Median (interquartile range)

Minimum/maximum

Rescue med refills

3.28 (3.90)

2 (0–5)

0/17

4.00 (3.86)

3 (1–6)

0/19

Control med refills

2.80 (4.92)

1 (0–3.25)

0/27

3.71 (6.82)

1 (0–4)

0/32

Steroids

0.67 (1.16)

0 (0–1)

0/5

1.04 (1.18)

1 (0–2)

0/5

Hospitalizations

2 among 2 participants

2 among 2 participants

General clinic visits

2.67 (4.80)

1 (0–3)

0/32

2.00 (2.06)

1.5 (0–3)

0/8

Total ED visits

1.18 (1.88)

1 (0–1)

0/8

1.08 (1.66)

0.5 (0–2)

0/9

Participants with any ED visit

26/49(53%)

26/52(50%)